CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-07 | Van Tuyl Christopher Chief Legal Officer | Sale | −1,327 | $32.06 | $43K | 175,218 |
| 2026-09-23 | Van Tuyl Christopher Chief Legal Officer | Sale | −2,846 | $36.36 | $103K | 176,545 |
| 2026-07-08 | Van Tuyl Christopher Chief Legal Officer | Sale | −1,143 | $39.53 | $45K | 179,454 |
| 2026-07-08 | Van Tuyl Christopher Chief Legal Officer | Sale | −63 | $39.99 | $3K | 179,391 |
| 2026-06-26 | Van Tuyl Christopher Chief Legal Officer | Option exercise | +17,824 | $15.20 | $271K | 198,421 |
| 2026-06-26 | Van Tuyl Christopher Chief Legal Officer | Sale | −14,982 | $38.19 | $572K | 183,439 |
| 2026-06-26 | Van Tuyl Christopher Chief Legal Officer | Sale | −2,842 | $38.96 | $111K | 180,597 |
| 2026-06-26 | Van Tuyl Christopher Chief Legal Officer | Option exercise · Stock Option (right to buy) | −17,824 | 53,707 | ||
| 2026-06-18 | Van Tuyl Christopher Chief Legal Officer | Sale | −2,634 | $35.39 | $93K | 180,597 |
| 2026-04-08 | Van Tuyl Christopher Chief Legal Officer | Sale | −5,165 | $24.83 | $128K | 183,231 |
| 2026-04-07 | Van Tuyl Christopher Chief Legal Officer | Grant or award | +41,343 | 188,396 | ||
| 2026-04-07 | Van Tuyl Christopher Chief Legal Officer | Grant or award · Stock Option (right to buy) | +59,820 | 59,820 | ||
| 2026-03-18 | Van Tuyl Christopher Chief Legal Officer | Sale | −2,877 | $24.97 | $72K | 147,053 |
| 2025-12-18 | Van Tuyl Christopher Chief Legal Officer | Sale | −8,529 | $26.78 | $228K | 152,214 |
| 2025-12-18 | Van Tuyl Christopher Chief Legal Officer | Sale | −2,284 | $27.38 | $63K | 149,930 |
| 2025-04-01 | Van Tuyl Christopher Chief Legal Officer | Grant or award | +50,787 | 160,743 | ||
| 2025-04-01 | Van Tuyl Christopher Chief Legal Officer | Grant or award · Stock Option (right to buy) | +71,531 | 71,531 | ||
| 2024-12-16 | Van Tuyl Christopher Chief Legal Officer | Grant or award | +109,956 | 109,956 | ||
| 2024-12-16 | Van Tuyl Christopher Chief Legal Officer | Grant or award · Stock Option (right to buy) | +137,446 | 137,446 |
Page 1 of 1 · 19 trades